This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...

This paper analyses the impact of patents on the dynamics of new drug introduction into different national markets. By studying a set of markets for HIV/AIDS drugs in a sample of developing countries, we find that patents only make the introduction of new drugs significantly quicker in the case...

This paper studies the incentives that developing countries have to protect intellectual properties rights (IPR). On the one hand, free-riding on rich countries technology reduces their investment cost in R&D. On the other hand, firm that violates IPR cannot legally export in a country that...

This paper aims to contribute to frame the IP for development debate into a more extensive discussion on appropriability, within the perspective of policies shaping scientific, technological and production capabilities in the light of development theory. Through the lenses of the paradigm based...

This chapter explores the role of regional innovation systems supporting capability building among indigenous SMEs in two different RIS in Mexico. It explicitly attempts at testing the validity of the underlying assumptions in RIS literature in the context of developing countries, such as the...

Innovation systems in developing countries differ largely from those in developed countries. A typical difference is that less developed countries have weaker institutional frameworks and low levels of interaction among the different actors in the innovation system. Scholars in innovation system...

The global location of R&D centres by MNCs is a rather new phenomenon; especially when it comes to establishing R&D centres in developing countries. The existing and rather limited literature on globalization of innovation provides four possible explanations of why multinationals locate R&D...

Compulsory licensing allows firms in developing countries to produce foreign-owned inventions without the consent of foreign patent owners. This paper uses an exogenous event of compulsory licensing after World War I under the Trading with the Enemy Act to examine the effects of compulsory...